Avesthagen Limited
PrivateLast Round
Early Funding
Aug 8, 2023
Est. Valuation
$155.25M
Total Funding Raised
$105.28M
Company Overview
Avesthagen Limited is a biotechnology company that operates an integrated systems biology platform focused on the convergence of food, pharmaceuticals, and population genetics to develop products for healthcare, wellness, and agriculture.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avesthagen Limited Comparables
Compare Avesthagen Limited with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Clevergene | 76% | |
| Reliance Industries | 75% | |
| Genotypic Technology | 75% |
Avesthagen Limited Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Aug 8, 2023 | ||||
| Grant | Oct 1, 2019 | ||||
| Series C | Feb 5, 2013 | ||||
| VC Round | May 1, 2012 | ||||
| Debt | Sep 10, 2010 | ||||
VC Round | Jan 22, 2008 |
Avesthagen Limited Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ICICI Venture | Series A |
| Biotechnology Industry Research Assistance Council | Debt |
| Amrex Ventures | Series C |
| Cipla | Strategic |
| Danone | Series C |
| Daninvest | Series C |
| Godrej Industries | Series B, Strategic |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2019
$2.29M grant received from Global Action to End Smoking.
- Jan 22, 2008
Raised $6M in a VC Round.
Avesthagen Limited Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Avesthagen Limited's valuation, stock price, and market status.
Is Avesthagen Limited a public or private company?
Avesthagen Limited is a private company.
What is the current stock price of Avesthagen Limited?
Avesthagen Limited is a private company with no public stock price. No recent secondary market data is available.
How much is Avesthagen Limited worth (valuation)?
Avesthagen Limited's valuation is estimated at $155.3M based on funding round data.
Can I buy Avesthagen Limited stock?
Avesthagen Limited shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Avesthagen Limited's last funding round?
Avesthagen Limited's most recent funding round was Series C on February 5, 2013.
Who are the main investors in Avesthagen Limited?
Key investors in Avesthagen Limited include ICICI Venture, Godrej Industries.
Will Avesthagen Limited IPO soon?
No public IPO plans have been announced for Avesthagen Limited.
How can I track Avesthagen Limited secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Avesthagen Limited's secondary market activity and sign up for updates.